Erythema annulare centrifugum following SARS‐CoV‐2 infection in a pediatric patient
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Dermatology"
DOI: 10.1111/ijd.16194
Abstract: rucaparib. This switch resulted in a key approach to prevent new relapses, allowing the continuation of PARP inhibitors. Dermatologists and oncologists need to be aware of the existence of skin toxicities due to PARP inhibitors… read more here.
Keywords: centrifugum following; erythema annulare; following sars; parp inhibitors ... See more keywords